Eptifibatide injection approved by USFDA，from Nanjing King-Friend subsidiary
May 9, 2024, Hong Kong King-Friend Industrial Company Limited. (hereinafter referred to as "HKF"), a subsidiary of Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. (hereinafter referred to as "NKF"), received the approval letter from the US Food and Drug Administration (FDA) for Eptifibatide injection.
